IndiaTickerCertificate under SEBI (Depositories and Participants) Regulations, 2018 - Suraksha Diagnostic LimitedNSE · exchange filing · pdf
Source filing Company dossier
Suraksha Diagnostic
NSE:SURAKSHA · ISIN INE877V01027
- Close
- ₹248.85 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Suraksha Diagnostic
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Suraksha Diagnostic Ltd - 544293 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Trading Window - Suraksha Diagnostic LimitedNSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Resignation of Director/KMP/SMP - Suraksha Diagnostic LimitedNSE · exchange filing · zip
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerBSE · exchange filing · pdf
Source filing Cessation - Suraksha Diagnostic LimitedNSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Suraksha Diagnostic LimitedNSE · conference call · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing Copy of Newspaper Publication - Suraksha Diagnostic LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Suraksha Diagnostic LimitedNSE · conference call · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Board Meeting Outcome for Meeting Held Today I.E 21 May 2026BSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Results -Financial Results For Quarter And Financial Year Ended 31 March 2026BSE · financial results · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · financial results · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Corporate Action-Board approves DividendBSE · corporate action · pdf
Source filing Outcome of Board Meeting - Suraksha Diagnostic LimitedNSE · financial results · pdf
Source filing Investor Presentation - Suraksha Diagnostic LimitedNSE · investor presentation · pdf
Source filing Press Release - Suraksha Diagnostic LimitedNSE · financial results · pdf
Source filing Dividend - Suraksha Diagnostic LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Suraksha Diagnostic LimitedNSE · financial results · pdf
Source filing Outcome of Board Meeting - Suraksha Diagnostic LimitedNSE · financial results · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Suraksha Diagnostic LimitedNSE · conference call · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Board Meeting Intimation for Inter-Alia, Considering And Approving Audited (Standalone And Consolidated) Financial Results Of The Company For Quarter And FY 2025-26 And To Consider Recommendation Of Dividend, If Any, On Equity Shares Of Company For FY 2025-26.BSE · financial results · pdf
Source filing Disclosure under SEBI Takeover Regulations - Suraksha Diagnostic LimitedNSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Suraksha Diagnostic LimitedNSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Suraksha Diagnostic LimitedNSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Trading Window - Suraksha Diagnostic LimitedNSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)BSE · exchange filing · pdf
Source filing Suraksha Diagnostic Ltd - 544293 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Suraksha Diagnostic LimitedNSE · conference call · pdf
Source filing